UK markets open in 3 hours 11 minutes

ME Therapeutics Holdings Inc. (Q9T.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
2.50000.0000 (0.00%)
At close: 03:29PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/08/2023
30/09/2022
31/08/2022
Total revenue
0
0
0
0
Operating expenses
Research development
172.975
27.117
54.672
54.672
Selling general and administrative
1,244
950.205
257.534
97.251
Total operating expenses
1,398
977.371
295.267
134.984
Operating income or loss
-1,398
-977.371
-295.267
-134.984
Interest expense
0
7.462
10.8
10.8
Total other income/expenses net
-
-5,547
-3,002
-
Income before tax
-6,928
-6,520
-3,305
-145.784
Income from continuing operations
-6,928
-6,520
-3,305
-145.784
Net income
-6,928
-6,520
-3,305
-145.784
Net income available to common shareholders
-6,928
-6,520
-3,305
-145.784
Basic EPS
-0.28
-0.28
-
-0.01
Diluted EPS
-0.28
-0.28
-
-0.01
Basic average shares
23,561
23,561
-
23,176
Diluted average shares
23,561
23,561
-
23,176